
BridgeBio Pharma, Inc.: shareholders and insiders
Price
$76.80
November 17, 2026Market cap $14.9B
What Ploutos Investor adds for BridgeBio Pharma
Part of Ploutos Investor, €9.99 a month
- The full history: 7 fiscal years, from 2019
- The estimated fair value, with its range and its certainty
- The full analysis, 18 a month
- More questions to the chat on its filings
- Excel with every year
- An email when it reports, changes its dividend or an officer buys
Sign in with a free account to see the last 5 fiscal years.
Insiders and their shares
Purchases and sales by officers and directors, from their own Form 4 filings.
Reading the newest filings from the SEC. This part fills in on its own in a few seconds.
Major holders (over 5%)
Whoever comes to own more than 5% of a class of shares reports it to the SEC on Schedule 13D or 13G. Here is each holder's latest filing.
- Farallon Capital Management, L.L.C.with 15 more personsShare of class7.30%
- Janus Henderson GroupShare of class6.80%
- BlackRock, Inc.Share of class5.10%
- Viking Global Investorswith 6 more personsShare of class5.00%
| Holder | Kind of stake | Share of class | Shares | Filed | Filing |
|---|---|---|---|---|---|
| Farallon Capital Management, L.L.C.with 15 more persons | 7.30% | 14.25M | Nov 12, 20263 filings since May 29, 2026 | 13G/A | |
| Janus Henderson Group | 6.80% | 13.18M | May 15, 20262 filings since Feb 17, 2026 | 13G/A | |
| BlackRock, Inc. | 5.10% | 9.89M | Oct 27, 20262 filings since Jul 27, 2026 | 13G | |
| Viking Global Investorswith 6 more persons | 5.00% | 9.79M | Jul 10, 20268 filings since Jan 31, 2025 | 13D/A |
What the holders on a 13D state as their purpose
From Item 4 of the filing, in the holder's own words. It is the intention the holder states, not something that happened.
Viking Global Investors5.0%From the filing of Jan 31, 2025
Item 4 of the Schedule 13D is hereby amended and supplemented as follows: On January 31, 2025, VGEM, VLFM and Opportunities Fund sold 143,266 shares of Common Stock, 57,020 shares of Common Stock and 2,865,330 shares of Common Stock, respectively, at a price of $34.90 per share.
From the filing of Jan 31, 2025
Fell to 5% or less (4)
Holders whose latest filing says they hold 5% or less. After it they need not file again, so what they hold today is not known.
From the Schedule 13D and 13G filed with the SEC since Dec 18, 2024, when they became structured data. A holder who has filed nothing since then is not shown here. A 13D is updated within two business days of any material change, a 13G up to 45 days after the quarter of the change, so the shares are those of the filing. The large managers also appear in the 13Fs.
Well-known managers
Which of the about 30 investment managers we track held the shares at the quarter end, and what they changed from the quarter before.
- Viking Global (Halvorsen)In the quarter-16%
- Point72 (Cohen)In the quarter
- D.E. ShawIn the quarter+43%
- Citadel Advisors (Griffin)In the quarter+18%
- Bridgewater (Dalio)In the quarter+73%
- Renaissance TechnologiesIn the quarter-0.0%
- Millennium Mgmt (Englander)In the quarter-23%
- AQR CapitalIn the quarter+4.3%
| Manager | Shares | In the quarter | Value | % of their portfolio |
|---|---|---|---|---|
| Viking Global (Halvorsen) | 9.95M | -16% | $741M | 2.11% |
| Point72 (Cohen) | 1.53M | $114M | 0.17% | |
| D.E. Shaw | 3.63M | +43% | $271M | 0.17% |
| Citadel Advisors (Griffin) | 3.76M | +18% | $280M | 0.16% |
| Bridgewater (Dalio) | 448.1K | +73% | $33M | 0.14% |
| Renaissance Technologies | 856.5K | -0.0% | $56M | 0.08% |
| Millennium Mgmt (Englander) | 487.6K | -23% | $36M | 0.02% |
| AQR Capital | 166.9K | +4.3% | $12M | 0.00% |
From the 13Fs managers file with the SEC up to 45 days after each quarter end. They show only long positions on that day, not short sales or what has changed since. No recent 13F: Pershing Square (Ackman), Scion (Burry).
Short interest
How many of the company's shares have been sold borrowed and not yet bought back, twice a month.
On Oct 15, 2026, 10.3% of its shares outstanding were held short, +1.7% since the report before.
- Shares held short
- 20.00M
- 10.3%
- Since the report before19.67M on Sep 30, 2026
- +1.7%
- 7.7
- 2.60M
- More days to cover thanof 4,578 US-listed companies with enough volume
- 82%
- Report date
- Oct 15, 2026
- Shares held short
- Oct 31, 2023: Shares held short 15.97M
- Nov 15, 2023: Shares held short 16.28M
- Nov 30, 2023: Shares held short 15.96M
- Dec 15, 2023: Shares held short 17.09M
- Dec 29, 2023: Shares held short 17.08M
- Jan 12, 2024: Shares held short 16.12M
- Jan 31, 2024: Shares held short 14.21M
- Feb 15, 2024: Shares held short 14.00M
- Feb 29, 2024: Shares held short 13.64M
- Mar 15, 2024: Shares held short 13.41M
- Mar 28, 2024: Shares held short 14.28M
- Apr 15, 2024: Shares held short 15.07M
- Apr 30, 2024: Shares held short 16.23M
- May 15, 2024: Shares held short 15.78M
- May 31, 2024: Shares held short 16.63M
- Jun 14, 2024: Shares held short 16.66M
- Jun 28, 2024: Shares held short 20.00M
- Jul 15, 2024: Shares held short 21.05M
- Jul 31, 2024: Shares held short 19.96M
- Aug 15, 2024: Shares held short 18.02M
- Aug 30, 2024: Shares held short 17.71M
- Sep 13, 2024: Shares held short 19.61M
- Sep 30, 2024: Shares held short 18.63M
- Oct 15, 2024: Shares held short 17.78M
- Oct 31, 2024: Shares held short 17.20M
- Nov 15, 2024: Shares held short 17.19M
- Nov 29, 2024: Shares held short 17.00M
- Dec 13, 2024: Shares held short 17.12M
- Dec 31, 2024: Shares held short 19.30M
- Jan 15, 2025: Shares held short 20.38M
- Jan 31, 2025: Shares held short 18.78M
- Feb 14, 2025: Shares held short 20.18M
- Feb 28, 2025: Shares held short 22.16M
- Mar 14, 2025: Shares held short 21.76M
- Mar 31, 2025: Shares held short 21.71M
- Apr 15, 2025: Shares held short 22.31M
- Apr 30, 2025: Shares held short 22.18M
- May 15, 2025: Shares held short 22.40M
- May 30, 2025: Shares held short 21.99M
- Jun 13, 2025: Shares held short 21.12M
- Jun 30, 2025: Shares held short 21.83M
- Jul 15, 2025: Shares held short 19.48M
- Jul 31, 2025: Shares held short 18.52M
- Aug 15, 2025: Shares held short 20.49M
- Aug 29, 2025: Shares held short 19.91M
- Sep 15, 2025: Shares held short 19.44M
- Sep 30, 2025: Shares held short 17.49M
- Oct 15, 2025: Shares held short 17.35M
- Oct 31, 2025: Shares held short 19.57M
- Nov 14, 2025: Shares held short 20.69M
- Nov 28, 2025: Shares held short 19.38M
- Dec 15, 2025: Shares held short 18.79M
- Dec 31, 2025: Shares held short 17.21M
- Jan 15, 2026: Shares held short 18.37M
- Jan 30, 2026: Shares held short 19.98M
- Feb 13, 2026: Shares held short 21.17M
- Feb 27, 2026: Shares held short 21.96M
- Mar 13, 2026: Shares held short 23.51M
- Mar 31, 2026: Shares held short 23.37M
- Apr 15, 2026: Shares held short 22.68M
- Apr 30, 2026: Shares held short 24.03M
- May 15, 2026: Shares held short 24.16M
- May 29, 2026: Shares held short 24.39M
- Jun 15, 2026: Shares held short 25.42M
- Jun 30, 2026: Shares held short 24.10M
- Jul 15, 2026: Shares held short 25.75M
- Jul 31, 2026: Shares held short 23.34M
- Aug 14, 2026: Shares held short 23.32M
- Aug 31, 2026: Shares held short 21.85M
- Sep 15, 2026: Shares held short 21.55M
- Sep 30, 2026: Shares held short 19.67M
- Oct 15, 2026: Shares held short 20.00M
As brokers report them to the regulator twice a month, mid-month and at month end, published about eight business days later. A short position is shares sold borrowed and not yet bought back. The share count is the one the company's market value is figured on, from its filings. Days to cover is the shares held short over the average daily volume of the weeks between two reports.
Short sales in daily trading50.1% of the shares in the last 14 sessions' reported trades were short sales.
In the last 14 sessions, 50.1% of the shares in the reported trades were short sales, against 58.2% in the 14 before.
- Last 14 sessionsOct 29, 2026 – Nov 17, 2026
- 50.1%
- The 14 beforeOct 9, 2026 – Oct 28, 2026
- 58.2%
- Change
- -8.1 pts
- Short sales a dayon average, of 1.48M shares
- 741.0K
- More than atof 3,666 US-listed companies, same days
- 49%
- Median of alleight in ten from 34.6% to 63.7%
- 50.3%
- Short sales
- Oct 9, 2026: Short sales 37.9%
- Oct 12, 2026: Short sales 56.2%
- Oct 13, 2026: Short sales 52%
- Oct 14, 2026: Short sales 44.8%
- Oct 15, 2026: Short sales 44.9%
- Oct 16, 2026: Short sales 59.9%
- Oct 19, 2026: Short sales 47.7%
- Oct 20, 2026: Short sales 61.3%
- Oct 21, 2026: Short sales 75.7%
- Oct 22, 2026: Short sales 43.6%
- Oct 23, 2026: Short sales 67.1%
- Oct 26, 2026: Short sales 48.3%
- Oct 27, 2026: Short sales 71.3%
- Oct 28, 2026: Short sales 72.4%
- Oct 29, 2026: Short sales 65.8%
- Oct 30, 2026: Short sales 42%
- Nov 2, 2026: Short sales 49.3%
- Nov 3, 2026: Short sales 39%
- Nov 4, 2026: Short sales 42.1%
- Nov 5, 2026: Short sales 35.2%
- Nov 6, 2026: Short sales 24.1%
- Nov 9, 2026: Short sales 69%
- Nov 10, 2026: Short sales 66.9%
- Nov 11, 2026: Short sales 50.5%
- Nov 12, 2026: Short sales 36.9%
- Nov 13, 2026: Short sales 54.9%
- Nov 16, 2026: Short sales 53.5%
- Nov 17, 2026: Short sales 60.7%
This is not the number of shares sold short today: it measures short sales within each day's trading, and only trades made off the exchanges. Much of it is market makers, who sell shares they do not have to fill buyers' orders and cover soon after, so for a heavily traded stock the share is often around half.
The ETFs that hold it
Which of the 345 US equity ETFs we track hold the stock, and at what weight, from the funds' N-PORT filings.
- XBIState Street(R) SPDR(R) S&P(R) Biotech ETFWeight in the fund1.02%
- IBBiShares Biotechnology ETFWeight in the fund0.98%
- LABUDirexion Daily S&P Biotech Bull 3X SharesWeight in the fund0.81%
- VBKVanguard Small-Cap Growth Index FundWeight in the fund0.37%
- IWPiShares Russell Mid-Cap Growth ETFWeight in the fund0.32%
- SCHASchwab U.S. Small-Cap ETFWeight in the fund0.28%
- FESMFidelity Enhanced Small Cap Core ETFWeight in the fund0.27%
- SCHMSchwab U.S. Mid-Cap ETFWeight in the fund0.25%
- IYHiShares U.S. Healthcare ETFWeight in the fund0.22%
- VBVanguard Small-Cap Index FundWeight in the fund0.16%
29 of the 345 ETFs we track, not of every ETF on the market. The ten largest weights. Positions as each fund filed them in its latest N-PORT.
Institutional investors by quarter
Every manager that reports positions to the SEC (Form 13F), quarter by quarter: how many hold the stock, how many shares and dollars between them, and who entered, left, added or trimmed during the quarter.
- Managers
- Q3 2025: Managers 394
- Q4 2025: Managers 434
- Q1 2026: Managers 464
- Q2 2026: Managers 474
Institutional investors by quarter
The fund managers holding BBIO, quarter by quarter, from Q2 2019 to Q2 2025, 25 more quarters
Part of Ploutos Investor, €9.99 a month
Sign in with a free account to see the last 12 quarters.
Q2 2026: 474 managers held 194M shares, worth $14.4B. During the quarter 85 opened a position, 75 closed one, 168 added and 164 trimmed.
The largest holders, Q2 2026
- Jupiter TopcoIn the quarter
- Kohlberg Kravis RobertsIn the quarter
- Farallon Capital ManagementIn the quarter+15%
- BlackRockIn the quarter-28%
- Viking Global (Halvorsen)In the quarter-16%
- Vanguard Capital ManagementIn the quarter+1.8%
- Vanguard Portfolio ManagementIn the quarter-5.2%
- Wellington Management GroupIn the quarter+114%
- Two Sigma InvestmentsIn the quarter+51%
- Aisling Capital ManagementIn the quarter-9.8%
| Manager | Shares | In the quarter | Value |
|---|---|---|---|
| Jupiter Topco | 14.11M | $1.1B | |
| Kohlberg Kravis Roberts | 13.26M | $988M | |
| Farallon Capital Management | 10.74M | +15% | $800M |
| BlackRock | 10.29M | -28% | $766M |
| Viking Global (Halvorsen) | 9.95M | -16% | $741M |
| Vanguard Capital Management | 7.90M | +1.8% | $588M |
| Vanguard Portfolio Management | 7.66M | -5.2% | $570M |
| Wellington Management Group | 5.31M | +114% | $395M |
| Two Sigma Investments | 4.72M | +51% | $352M |
| Aisling Capital Management | 4.59M | -9.8% | $342M |
From the SEC's Form 13F data sets, Q3 2025 to Q2 2026: the long positions of every manager with more than $100 million under management, as filed up to 45 days after each quarter end. Short positions and options are not in them. Shares as reported each quarter, not adjusted for splits. The stock is matched by its CUSIP, through the SEC's fails-to-deliver files.
Pay against performance, the say-on-pay vote, buybacks by quarter and trading plans are read for S&P 500 companies only.
The full analysis
What do BridgeBio Pharma's filings show?
Who buys and sells is one part of BridgeBio Pharma's picture. The full Ploutos AI analysis reads everything the company has filed and shows what stands behind it, with a source for every figure.
- A fair value range built from the filings
- Earnings quality, debt and red flags
- Insider and institutional moves
- The case for and the case against
Which well-known managers hold BBIO?
8 of the managers we track held the shares on Sep 30, 2026. The largest position was Viking Global (Halvorsen)'s, worth $741M.
Is every insider transaction a purchase or a sale?
No. Many are part of their pay: share awards, option exercises and shares the company keeps for the tax. Only code P is a purchase with their own money, and code S a sale on the market.
Related pages
The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.
The figures come from the company's SEC filings and the share price, and describe what it has reported. They are not a score or a fair value.